PubMed:32338224 / 10324-10482 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-OGER-BB

Id Subject Object Predicate Lexical cue
T304 60-70 CHEBI:35222 denotes inhibitors
T305 60-70 CHEBI:35222 denotes inhibitors
T306 115-123 SP_7 denotes COVID-19
T307 153-157 G_3 denotes ACE2
T308 153-157 PG_10 denotes ACE2

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T62 115-123 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T63 124-133 Disease denotes infection http://purl.obolibrary.org/obo/MONDO_0005550

LitCovid-PD-CHEBI

Id Subject Object Predicate Lexical cue chebi_id
T65 56-70 Chemical denotes ACE inhibitors http://purl.obolibrary.org/obo/CHEBI_35457
T66 60-70 Chemical denotes inhibitors http://purl.obolibrary.org/obo/CHEBI_35222
T67 74-77 Chemical denotes ANG http://purl.obolibrary.org/obo/CHEBI_48433
T68 78-80 Chemical denotes II http://purl.obolibrary.org/obo/CHEBI_74067

PubMed_ArguminSci

Id Subject Object Predicate Lexical cue
T64 0-158 DRI_Outcome denotes In fact, there are no available data which support that ACE inhibitors or ANG II type I receptor blockers increase COVID-19 infection via its binding to ACE2.

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T64 0-158 Sentence denotes In fact, there are no available data which support that ACE inhibitors or ANG II type I receptor blockers increase COVID-19 infection via its binding to ACE2.